Non-contact heart rate variability monitoring using Doppler radars located beneath bed mattress: a case report. Issue 8 (9th August 2021)

• Record Type: Journal Article
• Authors: Otake, Yusuke; Kobayashi, Tsuyoshi; Hakozaki, Yukiya; Matsui, Takemi
• Editors: Wong, Christopher; Kennel, Peter J; Vanezis, Andrew Peter; Parollo, Matteo; Sunjaya, Anthony Paulo
• Is Part Of: European heart journal. Volume 5:Issue 8(2021)
• Publication Date: 2021-08-09
• Subjects: Sepsis -- Autonomic nervous activity -- Heart rate variability -- Cheyne-Stokes respiration -- Non-contact monitoring -- Case report; Cardiology -- Periodicals; Cardiology -- Case studies -- Periodicals; Heart -- Diseases -- Periodicals; Heart -- Diseases -- Case studies -- Periodicals; 616.12
• DOI: 10.1093/ehjcr/ytab273
• Languages: English
• ISSNs: 2514-2119

Abstract

Abstract: Background: Heart rate variability (HRV) has been investigated previously in autonomic nervous system-related clinical settings. In these settings, HRV is determined by the time-series heartbeat peak-to-peak intervals using electrocardiography (ECG). To reduce patient discomfort, we designed a Doppler radar-based autonomic nervous activity monitoring system (ANMS) that allows cardiopulmonary monitoring without using ECG electrodes or spirometry monitoring. Case summary: Using our non-contact ANMS, we observed a bedridden 80-year-old female patient with terminal phase sepsis developed the daytime Cheyne-Stokes respiration (CSR) associated with the attenuation of the low frequency (LF) and high frequency (HF) of HRV components 20 days prior to her death. The patient developed a marked linear decrease in the LF and the HF of HRV components for over 3 days in a row. Furthermore, after the decrease both the LF and the HF showed low and linear values. Around the intersection of the two lines, the decreasing LF and HF lines and the constant LF and HF lines, the ANMS automatically detected the daytime CSR pathogenesis. The attenuation rate of HF (1340 ms 2 /day) was higher than that of LF (956 ms 2 /day). Heart rate increased by ∼10 b.p.m. during these 3 days. Discussion: We detected CSR-associated LF and HF attenuation in a patient with terminal phase sepsis using our ANMS. The proposed system without lead appears promising for future applications in clinical settings, such as remote cardiac monitoring of patients with heart failure at home or in long-term acute care facilities.